Quantabio Launches Ultra-Sensitive sparQ mRNA-Seq Kit
BEVERLY, Mass. – June 8th, 2023 – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and…
BEVERLY, Mass. – June 8th, 2023 – Quantabio, a leading provider of robust DNA and RNA amplification reagents for the most demanding molecular testing and…
Bangkok, Thailand, June 7, 2023 – DKSH Business Unit Technology has signed an agreement with Quantabio, LLC. DKSH will provide full Market Expansion Services, including…
Avantor / VWR International recognizes exclusive partnership and continuous commitment to product quality, performance and operational excellence Quantabio today announced that it was named 2023…
Join our upcoming webinar to introduce the next generation of PCR amplification technology: Significant improvements to PCR amplification enables better performance for a multitude of…
New optimizations increase yields up to 5x, accelerate workflows by more than 35% and reduce sample preparation costs by up to 30% BEVERLY,…
Fast, flexible and easy-to-use qScript Ultra Flex Kit and qScript Ultra SuperMix enable scientists to reverse transcribe longer targets and maximize yields from challenging samples…
sparQ RNA-Seq HMR Kit generates high-quality Illumina® NGS sequencer-ready libraries from intact or degraded samples in a single day BEVERLY, Mass. – March 01…
Quantabio’s UltraPlex 1-Step ToughMix Added to SalivaDirect Emergency Use Authorization Protocol Ready-to-use, one-step master mix increases SARS-CoV-2 RT-PCR assay efficiency, sensitivity and specificity with minimal…
Today we are launching our newest next generation sequencing product, sparQ UDI Adapters, to better enable you with a complete library prep solution for sequencing on…
sparQ Universal Library Quant Kit provides rapid and accurate quantification of libraries prepared for sequencing on Illumina® NGS platforms. Accurate quantification of the number of amplifiable…
qScript 1-Step Virus ToughMix is a 2x, ready-to-use, master mix for rapid detection of RNA viruses such as Flu-A, Flu-B, and SARS-CoV-2, using one-step, or…
CDC’s latest emergency use authorization for influenza SARS-CoV-2 assay validates Quantabio’s ability to multiplex up to five targets with high efficiency, sensitivity and specificity BEVERLY,…